Magle Chemoswed Holding AB (publ) (FRA:52X)

Market Cap	789.47K -97.8%
Revenue (ttm)	24.91M -3.4%
Net Income	-23.64M
EPS	-1.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0220
Previous Close	0.0045
Day's Range	0.0020 - 0.0220
52-Week Range	0.0020 - 1.8800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 2, 2026

About FRA:52X

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activitie...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1944
• Employees: 150
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 52X

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error